Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Factor VIII Deficiency Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Factor VIII Deficiency Treatmentmarket, defines the market attractiveness level of Factor VIII Deficiency Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Factor VIII Deficiency Treatment industry, describes the types of Factor VIII Deficiency Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Factor VIII Deficiency Treatment market and the development prospects and opportunities of Factor VIII Deficiency Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Factor VIII Deficiency Treatment market in Chapter 13.
By Player:
Pfizer
BioMarin Pharmaceutical
CSL
Novo Nordisk
Grifols
Alnylam Pharmaceuticals
Amarna Therapeutics
Bayer HealthCare
Biogen Idec
Catalyst Biosciences
Shire
By Type:
Prophylaxis
On-demand
Inhibitor
By End-User:
Hemophilia A drugs
Hemophilia A inhibitors treatment
Von Willebrand disease treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Factor VIII Deficiency Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Factor VIII Deficiency Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Factor VIII Deficiency Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Factor VIII Deficiency Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Factor VIII Deficiency Treatment Market Analysis and Outlook to 2022
-
7.1 Global Factor VIII Deficiency Treatment Consumption (2017-2022)
-
7.2 United States Factor VIII Deficiency Treatment Consumption (2017-2022)
-
7.3 Europe Factor VIII Deficiency Treatment Consumption (2017-2022)
-
7.4 China Factor VIII Deficiency Treatment Consumption (2017-2022)
-
7.5 Japan Factor VIII Deficiency Treatment Consumption (2017-2022)
-
7.6 India Factor VIII Deficiency Treatment Consumption (2017-2022)
-
7.7 South Korea Factor VIII Deficiency Treatment Consumption (2017-2022)
8 Region and Country-wise Factor VIII Deficiency Treatment Market Analysis and Outlook to 2028
-
8.1 Global Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
8.2 United States Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
8.4 China Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
8.6 India Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
9 Global Factor VIII Deficiency Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Factor VIII Deficiency Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prophylaxis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global On-demand Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2 Global Factor VIII Deficiency Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hemophilia A drugs Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hemophilia A inhibitors treatment Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Von Willebrand disease treatment Consumption and Growth Rate (2017-2022)
10 Global Factor VIII Deficiency Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prophylaxis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global On-demand Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hemophilia A drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hemophilia A inhibitors treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Von Willebrand disease treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Factor VIII Deficiency Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Factor VIII Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Factor VIII Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Factor VIII Deficiency Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Factor VIII Deficiency Treatment Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Factor VIII Deficiency Treatment Product and Service
-
14.2 BioMarin Pharmaceutical
-
14.2.1 BioMarin Pharmaceutical Company Details
-
14.2.2 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Service
-
14.3 CSL
-
14.3.1 CSL Company Details
-
14.3.2 CSL Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CSL Factor VIII Deficiency Treatment Product and Service
-
14.4 Novo Nordisk
-
14.4.1 Novo Nordisk Company Details
-
14.4.2 Novo Nordisk Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novo Nordisk Factor VIII Deficiency Treatment Product and Service
-
14.5 Grifols
-
14.5.1 Grifols Company Details
-
14.5.2 Grifols Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Grifols Factor VIII Deficiency Treatment Product and Service
-
14.6 Alnylam Pharmaceuticals
-
14.6.1 Alnylam Pharmaceuticals Company Details
-
14.6.2 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Product and Service
-
14.7 Amarna Therapeutics
-
14.7.1 Amarna Therapeutics Company Details
-
14.7.2 Amarna Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amarna Therapeutics Factor VIII Deficiency Treatment Product and Service
-
14.8 Bayer HealthCare
-
14.8.1 Bayer HealthCare Company Details
-
14.8.2 Bayer HealthCare Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer HealthCare Factor VIII Deficiency Treatment Product and Service
-
14.9 Biogen Idec
-
14.9.1 Biogen Idec Company Details
-
14.9.2 Biogen Idec Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Idec Factor VIII Deficiency Treatment Product and Service
-
14.10 Catalyst Biosciences
-
14.10.1 Catalyst Biosciences Company Details
-
14.10.2 Catalyst Biosciences Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Catalyst Biosciences Factor VIII Deficiency Treatment Product and Service
-
14.11 Shire
-
14.11.1 Shire Company Details
-
14.11.2 Shire Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Shire Factor VIII Deficiency Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Factor VIII Deficiency Treatment
-
Figure Factor VIII Deficiency Treatment Picture
-
Table Global Factor VIII Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Factor VIII Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Factor VIII Deficiency Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure United States Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prophylaxis Consumption and Growth Rate (2017-2022)
-
Figure Global On-demand Consumption and Growth Rate (2017-2022)
-
Figure Global Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia A drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia A inhibitors treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Von Willebrand disease treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Prophylaxis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global On-demand Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia A drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia A inhibitors treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Von Willebrand disease treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Factor VIII Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Factor VIII Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Factor VIII Deficiency Treatment Product and Service
-
Table BioMarin Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Factor VIII Deficiency Treatment Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Factor VIII Deficiency Treatment Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Factor VIII Deficiency Treatment Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Product and Service
-
Table Amarna Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Amarna Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amarna Therapeutics Factor VIII Deficiency Treatment Product and Service
-
Table Bayer HealthCare (Foundation Year, Company Profile and etc.)
-
Table Bayer HealthCare Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Factor VIII Deficiency Treatment Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Factor VIII Deficiency Treatment Product and Service
-
Table Catalyst Biosciences (Foundation Year, Company Profile and etc.)
-
Table Catalyst Biosciences Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalyst Biosciences Factor VIII Deficiency Treatment Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Factor VIII Deficiency Treatment Product and Service
-
